PQ 736
736. Deputy Seán Crowe asked the Minister for Health if the Health Products Regulatory Authority, formerly the Irish Medicines Board, and the Health Service Executive had the known evidence of toxicity of mefloquine, the full phase III clinical mass trial results and the longitudinal study results for toxicity in targeted market anti-immune population studies on side effects of mefloquine toxicity prior to licensing it in 1989. [9875/16]
Introduced
17 May 2016
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
17 May 2016
Summary
736. Deputy Seán Crowe asked the Minister for Health if the Health Products Regulatory Authority, formerly the Irish Medicines Board, and the Health Service Executive had the known evidence of toxicity of mefloquine, the full phase III clinical mass trial results and the longitudinal study results for toxicity in targeted market anti-immune population studies on side effects of mefloquine toxicity prior to licensing it in 1989. [9875/16]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 17 May 2016
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2016-05-17/736/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2016-05-17/pq_736